Uncover the future of architecture with Autodesk's cloud-connected tools, ensuring design intent and project intelligence ...

FDA provided critical guidance for the advancement of CAD-1005 to pivotal Phase 3 in HITPhase 2 data showed a greater than 25% absolute reduction ...

Detailed price information for Cadrenal Therapeutics Inc (CVKD-Q) from The Globe and Mail including charting and trades.

Guill Tool, the global leader in extrusion tooling, has introduced its patent-pending Series 400 extrusion tooling, designed ...

Engineering teams are increasingly turning to cloud-based platforms to bridge the gap between remote, global, and multi-site operations. These tools enable real-time CAD collaboration, secure version ...

A flexible and cost-effective alternative to monolithic dies allows quick changeovers, reduced downtime, and long-term ...

Long-term success in cosmetic dentistry relies heavily on establishing stable functional bite mechanics before altering tooth aesthetics. Historically, dental restorations required manual putty ...

Annualized Advanced AI revenue at $620M; FY26 services revenue up 4.8% in CC; TCV of new deal wins at $9.3B. FY26 revenue grew 3.9% in constant currency (CC). USD revenue came in at $14.7 billion, up ...

Cadrenal is now planning a randomized, placebo-controlled study alongside standard anticoagulants. ・The company's Phase 2 data showed over a 25% reduction in clotting, though the trial missed its ...

On this episode of Tour Validated, Johnny Wunder and TaylorMade Tour rep Adrian Rietveld go in deep on how Rory, Tommy and ...

A Marathon construction and engineering business on April 21 filed a formal complaint with federal authorities against a U.S.

Oh, it's much worse than that. I recently heard Hope Giles, VP of Apple Hardware Technologies, talk about how Apple can't even find chip designers any more. She put up this slide from Semiconductor ...